EF
Empowered Funds’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.94M | Buy |
9,400
+7,207
| +329% | +$3.78M | 0.06% | 446 |
|
|
2025
Q1 | $1.39M | Sell |
2,193
-10,817
| -83% | -$6.86M | 0.02% | 889 |
|
|
2024
Q4 | $9.27M | Buy |
13,010
+11,358
| +688% | +$8.09M | 0.14% | 172 |
|
|
2024
Q3 | $1.74M | Buy |
1,652
+109
| +7% | +$115K | 0.03% | 720 |
|
|
2024
Q2 | $1.62M | Buy |
1,543
+190
| +14% | +$200K | 0.03% | 683 |
|
|
2024
Q1 | $1.3M | Buy |
1,353
+347
| +34% | +$334K | 0.02% | 762 |
|
|
2023
Q4 | $884K | Buy |
1,006
+123
| +14% | +$108K | 0.02% | 812 |
|
|
2023
Q3 | $727K | Buy |
883
+189
| +27% | +$156K | 0.02% | 780 |
|
|
2023
Q2 | $499K | Buy |
694
+243
| +54% | +$175K | 0.02% | 822 |
|
|
2023
Q1 | $371K | Buy |
+451
| New | +$371K | 0.02% | 430 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 404 |
|
|
2022
Q3 | – | Sell |
-7,006
| Closed | -$4.14M | – | 370 |
|
|
2022
Q2 | $4.14M | Buy |
7,006
+440
| +7% | +$260K | 0.53% | 54 |
|
|
2022
Q1 | $4.59M | Sell |
6,566
-1,038
| -14% | -$725K | 0.5% | 57 |
|
|
2021
Q4 | $4.8M | Buy |
+7,604
| New | +$4.8M | 0.54% | 71 |
|
|
2020
Q3 | – | Sell |
-2,268
| Closed | -$1.41M | – | 143 |
|
|
2020
Q2 | $1.41M | Buy |
+2,268
| New | +$1.41M | 0.55% | 61 |
|